HCM andamp; Felcyin-CA1: What You Need to Know with Dr. Ashlie Saffire | VETgirl Veterinary Continuing Education Podcasts
Update: 2025-09-08
Description
In today's VETgirl online veterinary continuing education podcast, Dr. Ashlie Saffire, DAVBP (feline practice), discusses Felcyin-CA1 (sirolimus delayed-release tablets), an FDA conditionally approved treatment option to slow the progression of hypertrophic cardiomyopathy (HCM) in cats manufactured by PRN Pharmacal. HCM is known as the silent killer in cats! Tune in to find out if Felycin-CA1 is the right choice for your HCM patient!
Sponsored By: PRN Pharmacal
Sponsored By: PRN Pharmacal
Comments
In Channel